Current and evolving treatment strategies in adult immune thrombocytopenia

about

Current and evolving treatment strategies in adult immune thrombocytopenia

Item

http://www.wikidata.org/entity/Q58775920

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 15 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Current and evolving treatment strategies in adult immune thrombocytopenia

@en

Current and evolving treatment strategies in adult immune thrombocytopenia

@nl

type

Item

label

Current and evolving treatment strategies in adult immune thrombocytopenia

@en

Current and evolving treatment strategies in adult immune thrombocytopenia

@nl

prefLabel

Current and evolving treatment strategies in adult immune thrombocytopenia

@en

Current and evolving treatment strategies in adult immune thrombocytopenia

@nl

P1476

Current and evolving treatment strategies in adult immune thrombocytopenia

@en

P2093

Michael Steurer

http://www.w3.org/2001/XMLSchema#string

P2860

Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review

International consensus report on the investigation and management of primary immune thrombocytopenia

Intravenous immunoglobulin for adults with autoimmune thrombocytopenic purpura: results of a randomized trial comparing 0.5 and 1 g/kg b.w.

A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: its development and validation.

Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura.

Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura

Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials.

Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial.

Short-term and long-term failure of laparoscopic splenectomy in adult immune thrombocytopenic purpura patients: a systematic review.

Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia.

P2888

s12254-018-0428-7

P304

241-246

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12254-018-0428-7

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jan-Paul Bohn

P577

2018-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30220932

http://www.w3.org/2001/XMLSchema#string

P921

hematology

thrombocytopenia

P932

6132792

http://www.w3.org/2001/XMLSchema#string